Researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery.

A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...

Women with an age at first birth younger than 26 or older than 35 years have a higher risk for developing rheumatoid arthritis later in life.

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

Discover how high-content imaging identifies drug responses and disease activity in rheumatoid arthritis, paving the way for personalized treatments.

Patients with rheumatoid arthritis are associated with an increased risk for heart failure, particularly heart failure with preserved ejection fraction.